Received: 1 July 2020
Accepted: 16 July 2020
First Online: 24 July 2020
Ethics approval and consent to participate
: A.D. was supported by the National Institutes for Health grant K23GM129660.R.H. has received no direct financial support, nor does he or his family hold patents or equity interest in any biotech or pharmaceutical company. He has received laboratory research support from Bristol-Myers Squibb, GlaxoSmithKline, and RevImmune; has served as a paid consultant to Bristol-Myers Squibb and GlaxoSmithKline; and has received grant support from the US NIH and US Public Health Service for research investigations of sepsis.E.K. has equity interest in Attune Medical.